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Abstract
Background: Human anion exchanger 1 and 2 (AE1 and AE2) mediate the exchange of Cl−/HCO3
− across the plasma
membrane and regulate intracellular pH (pHi). AE1 is specifically expressed on the surface of erythrocytes, while AE2
is widely expressed in most tissues, and is particularly abundant in parietal cells. Previous studies showed that an
interaction between AE1 and p16 is a key event in gastric cancer (GC) progression, but the importance of AE2 in GC
is unclear.
Methods: The relationship among AE1, AE2 and p16 in GC cells was characterized by molecular and cellular
experiments. AE2 expression and pHi were measured after knockdown or forced expression of AE1 or p16 in GC
cells. The effect of AE2 on GC growth and the correlation of AE2 expression with differentiation and prognosis of
GC were also evaluated. The effect of gastrin on AE2 expression and GC growth was investigated in cellular experiments
and mouse xenograft models.
Results: p16 binds to both AE1 and AE2 simultaneously. AE1 or p16 silencing elevated AE2 expression on the plasma
membrane where it plays a role in pHi regulation and GC suppression. AE2 expression was decreased in GC tissue, and
these decreased levels were correlated with poor differentiation and prognosis of GC. The low AE2 protein levels are due
to rapid ubiquitin-mediated degradation that was facilitated in the presence of p16. Gastrin inhibited the growth of GC
cells at least partially through up-regulation of AE2 expression.
Conclusion: AE1/p16 expression promoted AE2 degradation in GC cells. Gastrin is a potential candidate drug for targeted
therapies for AE1- and p16-positive GC.
Keywords: AE1, AE2, p16, Gastric cancer, Gastrin
Abbreviations: AE1, Anion exchanger 1; AE2, Anion exchanger 2; BCECF-AM, 2′,7′-bis-(2-carboxyethyl)-5-(and-6)-
carboxyfluorescein acetoxymethyl ester; CHX, Cycloheximide; GC, Gastric cancer; IP, Immunoprecipitation; MTT, 3-(4,5-
dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide; pHi, Intracellular pH; SLC4A1, Solute carrier family 4, anion
exchanger, member 1; SLC4A2, Solute carrier family 4, anion exchanger, member 2
Background
Gastric cancer (GC) is the fourth most common cancer
and the third most common cause of cancer-related
deaths worldwide. Despite advances in GC prevention
and treatment, the 5-year survival rate for this cancer
remains at 20–25 % [1]. GC can be classified into intes-
tinal (well- or moderately-differentiated) and diffuse
(poorly-differentiated) types based on histopathological
characteristics [2, 3]. In general, intestinal GC is associ-
ated with gastritis that might progressively lead to at-
rophy and metaplasia, dysplasia and finally cancer.
Although gastritis may, in some cases, account for dif-
fuse types of GC, this GC type does not arise via the
above-described cascade of histological events [4–6].
The AE family consists of AE1, AE2 and AE3 poly-
peptides that mediate electroneutral, Na+-independent,
plasmalemmal Cl−/HCO3
− exchange [7]. AE1 (also known
as band 3 or SLC4A1) is specifically expressed on the sur-
face of erythrocytes, where it constitutes nearly 50 % of
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the total integral membrane proteins [8, 9]. Meanwhile,
AE2 (SLC4A2) regulates intracellular pH (pHi), intra-
cellular chloride concentration, bicarbonate metabolism
and cell volume in a variety of cell types, but is most
abundant in gastric parietal cells [10–12], where AE2 is
required for the secretion of gastric acid to mediate
basolateral Cl− uptake, with additional contributions
from the Cl−/HCO3
− exchanger SLC26A7 and Na/K/2Cl
cotransporter, NKCC1 [13–16].
We previously found that AE1 is expressed in the
cytoplasm of GC cells and its C-terminal 112 residues
interacted with the tumor suppressor p16 [17, 18]. The
cytoplasmic AE1/p16 complex enhanced the stability of
both proteins and played a key role in GC progression,
which was correlated with short survival time of GC pa-
tients [19–21]. In addition, siRNA-mediated suppression
of AE1 significantly reduced the detection rate of GC in
an H. pylori-induced animal model of GC [22]. In this
study, we revealed that p16 binds not only AE1 but also
AE2, and that the formation of the AE1/p16 complex
accounted for the enhanced degradation of AE2 in poorly
differentiated GC cells. Moreover, gastrin, a major gastro-
intestinal hormone, could inhibit GC growth by blocking
AE1/p16-promoted AE2 degradation.
Methods
Cell culture and reagents
Human HEK293T cells, GC SGC7901 cells (AE1- and
p16-positive) and MKN28 cells (AE1- and p16-negative)
were cultured in DMEM/RPMI-1640 (Hyclone, Logan,
UT, USA) containing 10 % fetal bovine serum (FBS,
Hyclone) and 1 % penicillin/streptomycin (Invitrogen,
Carlsbad, CA, USA) in an atmosphere of 5 % CO2 at
37 °C. The following reagents were purchased from the
indicated companies: 2′,7′-bis-(2-carboxyethyl)-5-(and-
6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM)
(Dojindo Laboratories, Kumamoto, Japan), Cycloheximide
(CHX) (Sigma-Aldrich, St. Louis, MO, USA), MG132
(Merck KgaA Darmstadt, Germany) and 3-(4,5-dimethyl-
2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT)
(Sigma-Aldrich). Antibodies used for immunoblot ana-
lysis or IP experiments were included as follows: anti-
p16 (Santa Cruz, CA, USA; BD Pharmingen, USA),
anti-GFP (Santa Cruz), anti-HA (Santa Cruz) and anti-
β-actin (Sigma-Aldrich). The antibody used for immuno-
fluorescence and immunohistochemistry was anti-AE2
(Sigma-Aldrich).
Co-immunoprecipitation (co-IP) and immunoblot analysis
SGC7901 cells were lysed with Radioimmunoprecipita-
tion assay (RIPA) lysis buffer (Beyotime Institute of Bio-
technology, Shanghai, China) containing fresh protease
inhibitors and PMSF. The lysates were then incubated
with anti-p16 antibody (BD Pharmingen) overnight at
4 °C, followed by incubation with Protein G Plus/Protein
A Agarose Suspension (Merck) for another 4 h at 4 °C.
After washing 3 times with the ice-cold lysis buffer, pro-
teins were released from the beads using SDS lysis buffer
for 10 min at 95 °C and then resolved on 10 % SDS-PAGE
gels and analyzed by immunoblotting. To block the nitro-
cellulose membranes, 5 % skimmed milk in TBST was
used to reduce nonspecific background. Membranes were
then incubated with primary antibodies overnight at 4 °C.
After washing in TBST 3 times for 10 min each, mem-
branes were incubated with secondary antibodies for 1 h
at room temperature, and then washed again as before.
Bound antibodies were detected using a chemilumines-
cence phototope-horseradish peroxidase kit according
to the manufacturer’s instructions (Pierce, Rockford,
IL, USA).
Ubiquitination assay
SGC7901 cells were transfected with pEGFP-AE2a, HA-
Ub and p16 expression plasmids as indicated in Fig. 3c.
After transfection for 42 h, cells were treated with
10 μM MG132 for an additional 6 h and then harvested
and lysed in RIPA lysis buffer containing fresh protease
inhibitors and PMSF. Cell extracts were incubated with
anti-GFP antibody overnight at 4 °C, followed by incuba-
tion with the beads for another 4 h at 4 °C. After separ-
ation from the beads, the proteins were resolved by 8 %
SDS-PAGE gels and analyzed by immunoblotting with
anti-Ub antibody to detect ubiquitination.
Cell fractionation
SGC7901 cells were transfected with AE1- or p16-
targeted siRNA or shRNA plasmids separately. The cells
were then harvested and the cell fractionation experi-
ment was carried out using a Membrane and Cytosol
Protein Extraction Kit (Beyotime Biotechnology, China)
according to the manufacturer’s instructions.
Immunofluorescence
SGC7901 cells were seeded onto glass coverslips and
allowed to adhere for 24 h. After 15 min of fixation with
4 % paraformaldehyde, cells were permeabilized with
0.2 % Triton X-100 for 10 min at room temperature,
then washed with phosphate-buffered saline (PBS), and
blocked with 3 % bovine serum albumin (BSA). Cover-
slips were treated with primary antibodies at 4 °C over-
night. Following 3 brief washes with PBS, the coverslips
were incubated with appropriate secondary antibodies
for 1 h. The samples were imaged by the Radiance 2100
Laser Scanning System (Bio-Rad, Hertfordshire, UK).
DAPI was used to indicate the nuclei.
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Measurement of pHi
The pHi was measured using BCECF-AM in a Synergy H4
Hybrid Multi-Mode Microplate Reader (BioTek, Winooski,
VT, USA) as previously described. Briefly, the cells were
grown overnight in 96-well plates (Greiner Bio-One GmbH,
Frickenhausen, Germany). After washing twice with serum-
free DMEM, cells were incubated in serum-free DMEM
containing 1 μM BCECF-AM for 30 min at 37 °C in 5 %
humidified CO2. The cells were then washed with Ringer’s
buffer (140 mM NaCl or Na gluconate, 5 mM glucose,
5 mM potassium gluconate, 1 mM calcium gluconate,
1 mM MgSO4, 2.5 mM NaH2PO4, 25 mM NaHCO3,
10 mM HEPES, pH 7.4) three times and incubated in
Ringer’s buffer. BCECF-labeled cells were excited at 440
and 490 nm and emission was measured at 530 nm
using a Multi-Mode Microplate Reader. Fluorescence
excitation ratios were converted to pHi values using the
high K+-nigericin method by linear regression to a cali-
bration curve.
Estimation of cell viability
SGC7901 cells were seeded in 96-well plates and cul-
tured overnight, and then transfected with empty vectors
or AE2 expression vectors. At different time points,
10 μl of MTT (5 mg/ml) was added to each well and in-
cubated at 37 °C for 4 h. After carefully removing the
supernatant from each well, an equal volume of DMSO
(150 μl) was added to each well and mixed thoroughly.
The absorbance from the plates was read at 490 nm with
an ELISA reader.
Transwell cell migration assay
The transwell cell migration assay was performed using
transwell culture inserts (12-well, Corning, NY) accord-
ing to the manufacturer’s instructions. SGC7901 cells
were transfected with empty vectors or AE2 expression
vectors for 48 h. The cells were seeded onto the upper
chamber and allowed to migrate toward the lower face
of the transwell culture inserts. Cells were then incu-
bated at 37 °C for 20 h. The cells inside the upper cham-
ber were scraped off. Migrated cells on the underside of
the inserts were fixed in methanol, stained with gentian
violet and counted for 5 random 100× fields per well.
The cell number per image was determined by using
Image J software.
Immunohistochemistry
Paraffin-embedded gastric cancer samples and adjacent
normal tissue samples were collected from surgical resec-
tion and endoscopic biopsy performed at Renji hospital
and Ruijin hospital, Shanghai Jiao Tong University School
of Medicine. None of the patients had undergone chemo-
therapy or radiotherapy before surgery. All the specimens
were obtained according to protocols approved by the
Committee on Clinical Investigations of the respective in-
stitutions. Tumor specimens were fixed in 4 % neutralized
formaldehyde, embedded in paraffin and 4 μm sections
were stained with hematoxylin and eosin (H&E). For im-
munohistochemistry, sections were subjected to antigen
retrieval by incubation with citric acid (pH 6.0), and the
endogenous peroxidase was blocked by treatment with
3 % H2O2 for 15 min. After overnight incubation with pri-
mary antibodies at 4 °C, tissue sections were incubated for
15 min at room temperature with an appropriate second-
ary antibody (MaxVision™ Kits) followed by 3,3′-diamino-
benzidine staining, then counterstained with hematoxylin.
Normal rabbit IgG isotypes served as negative control
antibodies.
Mouse tumor model and therapy
Four-week-old female athymic BALB/c nude mice were
purchased from Shanghai Slac Laboratory Animal Co.,
Ltd. The principles governing the care and treatment of
animals as stated in the guidelines for the Care and Use
of Laboratory Animals, which was formulated by the
Ministry of Science and Technology of the People’s Re-
public of China were followed. Mouse experiments
were approved by the Animal Research Committee of
Shanghai Jiao Tong University. Nude mice were sub-
cutaneously injected into the flank with 5 × 106 SGC7901
cells suspended in 0.1 mL 0.9 % NaCl. Twenty xenograft
nude mice were prepared to investigate the effect of gas-
trin on gastric cancer growth. When tumors reached a
volume of 200 mm3, mice were randomized into either
the control group, which received 0.9 % NaCl subcutane-
ously, or into the therapeutic group, which received sub-
cutaneous injections of gastrin (2 mg/kg, diluted in 0.9 %
NaCl) twice daily. All mice were sacrificed after 20 days of
subcutaneous injection. Tumor length and width were
measured to calculate tumor volume (V) based on the
following formula: V = length (mm) ×width2 (mm)/2.
Fig. 1 p16 interacted with both AE1 and AE2 proteins. An IP experiment
was performed to examine endogenous interactions between AE1, AE2
and p16 in SGC7901 cells. Whole-cell lysates were immunoprecipitated
with rabbit anti-p16 antibodies, followed by detection of AE1, AE2
and p16
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Statistical analysis
SPSS 13.0 statistical package (SPSS, Inc., Chicago, IL,
USA) was used to analyze the experimental data. The
data were expressed as the mean ± SD. Comparisons be-
tween the two groups were performed with a t-test. The
χ2 test was used to analyze the rank data. Multiple com-
parisons were performed with one-way analysis of vari-
ance (ANOVA). Kaplan-Meier survival curves of two
groups were compared by log-rank test. Statistical differ-
ences were considered to be significant for p < 0.05.
Fig. 2 AE1 and p16 affected AE2 localization and expression in GC cells. a AE1 or p16 knockdown increased AE2 expression on the surface of
SGC7901 cells. Nuclei were stained with DAPI (blue). b AE1 and AE2 expression in the membrane and cytoplasmic fractions of SGC7901 cells was
detected by western blot. Cellular AE1 (up panel) and p16 (bottom panel) expression was suppressed by transfection with AE1- or p16-targeted
siRNA or shRNA. c, d Silencing of AE1 (c) or p16 (d) increased AE2 expression in SGC7901 cells as verified by western blot. The ratio of AE2 protein
abundance to that of β-actin was normalized to a value of 1.0 for SGC7901, *p < 0.05, compared with siRNA-NC/pSIREN-NC. e, f AE1 (e) or p16 (f)
overexpression reduced AE2 abundance in MKN28 cells. The ratio of AE2 protein abundance to that of β-actin was normalized to a value of 1.0
for MKN28, *p < 0.05, compared with empty vectors. The values are expressed as mean ± SD of three different experiments performed in triplicate
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Results
p16 interacted with both AE1 and AE2
Since AE1 has 80 % sequence similarity with AE2 in the
C-terminal region [7, 23], and the C-terminus of AE1
can interact with p16 as we previously showed [17, 19],
we hypothesized that p16 could also interact with the
AE2 C-terminus. To test this possibility we performed
an immunoprecipitation (IP) experiment using an anti-
p16 antibody in SGC7901 cells. The results showed that
the anti-p16 antibody precipitated detectable levels of
both endogenous AE1 and AE2 (Fig. 1).
AE1 and p16 interaction affected AE2 expression and
function
We previously reported that AE1 and p16 were largely
expressed in the cytoplasm of poorly-differentiated GC
SGC7901 cells, but were absent in well-differentiated
GC MKN28 cells [19, 20]. To further clarify the rela-
tionship among AE1, AE2 and p16, we down-regulated
AE1 or p16 expression in SGC7901 cells by transfection
with either AE1- or p16-targeted siRNA/shRNA
plasmids. Confocal microscopy and cell fractionation
experiments showed that individual knockdown of AE1
or p16 expression enhanced AE2 trafficking to the
plasma membrane and nuclear distribution (Fig. 2a, b)
and up-regulated AE2 expression (Fig. 2c, d). In contrast,
overexpression of AE1 or p16 in MKN28 cells down-
regulated AE2 expression (Fig. 2e, f ).
Cytoplasmic AE1/p16 promoted ubiquitin-dependent
degradation of AE2 in GC cells
We further speculated that the decreased levels of the
AE2 protein could be due to the instability that is poten-
tially associated with AE1 and p16 expression. To test this
possibility, AE2 levels in SGC7901 and MKN28 cells were
dynamically measured after the cells were treated with
cycloheximide (CHX), an inhibitor of protein biosyn-
thesis (25 μg/ml for SGC7901 cells and 50 μg/ml for
MKN 28 cells), or the proteasome inhibitor MG132
(10 μM). Western blots showed that after blocking
protein synthesis with CHX, the AE2 abundance in
SGC7901 cells rapidly decreased compared to that in
Fig. 3 p16 enhanced ubiquitin-dependent degradation of AE2 protein. a AE2 expression in two GC cell lines treated with CHX (25 μg/ml for
SGC7901 cells and 50 μg/ml for MKN28 cells) for the indicated times (left). The ratio of AE2 protein abundance to that of β-actin was normalized
to a value of 1.0 for 0 h (right). Data are representative of experiments performed three times in triplicate. AE2 was more stable in MKN28 cells
than in SGC7901 cells. b AE2 expression in two GC cell lines treated with 10 μM MG132 for the indicated times (left). Data are representative of
experiments performed three times in triplicate. The ratio of AE2 protein abundance to that of β-actin was normalized to a value of 1.0 for 0 h
(right). AE2 protein was more susceptible to degradation in SGC7901 cells than in MKN28 cells. c p16 enhanced ubiquitin-dependent degradation
of the AE2 protein. HEK293T cells were co-transfected with vectors expressing pEGFP-AE2a, HA-Ub and p16, singly or in combination, as indicated.
At 42 h after transfection, cells were treated with 10 μM MG132 for 6 h. Cell extracts were immunoprecipitated with anti-GFP antibodies to
reveal polyubiquitination
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MKN28 cells (Fig. 3a). Moreover, AE2 protein levels were
enriched more rapidly in SGC7901 cells than in MKN28
cells after treating the cells with MG132 (Fig. 3b). These
results indicated that AE2 was unstable in poorly differen-
tiated SGC7901 cells. To further test whether AE2 degrad-
ation was ubiquitin-dependent and was affected by p16
expression, a p16 expression vector was co-expressed with
HA-ubiquitin (HA-Ub) in SGC7901 cells. IP experiments
showed that polyubiquitin chains were present on GFP-
AE2 (Ub-AE2) in cells that overexpressed p16 and were
treated with MG132 (Fig. 3c). Taken together, these results
indicated that p16 enhanced ubiquitin-dependent degrad-
ation of the AE2 protein and promoted AE2 instability in
GC cells.
AE2 suppressed GC growth by decreasing pHi
Previous studies showed that the pHi was elevated in
AE1- and p16-positive SGC7901 cells and that cellular
Fig. 4 AE1 and p16 expression affected AE2 function. a Knockdown of AE1 or p16 expression reduced the pHi of SGC7901 cells. b AE1 or p16
overexpression increased the pHi of MKN28 cells. c AE2 overexpression reduced the pHi of SGC7901 cells. The pHi was measured using BCECF-AM.
d AE2 overexpression decreased GC cell proliferation. e AE2 overexpression in SGC7901 cells decreased the abundance of cyclin D1 (upper panel) in a
quantitative manner (bottom panel). f Transwell assay (upper panel) and statistical analysis (bottom panel). Values are expressed as mean ± SD of three
different experiments performed in triplicate. *p < 0.05, compared with empty vectors or siRNA-NC/pSIREN-NC
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alkalization favored cell proliferation [19, 24]. To explore
whether the pHi was affected by AE1 or p16 expression,
the pHi was measured after knockdown of AE1 or p16
expression in SGC7901 cells or over-expression of these
two proteins in AE1- and p16-negative MKN28 cells.
The results indicated that AE1 or p16 knockdown in
SGC7901 cells resulted in a significant reduction in pHi
compared with control cells (Fig. 4a). In contrast, AE1
or p16 overexpression in MKN28 cells significantly in-
creased the pHi (Fig. 4b). These results suggested that
AE2 might play a role in inhibition of GC cell prolifera-
tion. Forced AE2 expression in SGC7901 cells confirmed
that the GFP-AE2 significantly decreased the pHi of the
cells, and this decrease was accompanied by decreased
cyclin D1 expression as well as GC growth and migra-
tion (Fig. 4c-f ).
Fig. 5 Low levels of AE2 and high levels of AE1 and p16 correlated with poor survival of GC patients. a Abundant amounts of AE2 were detected
in adjacent normal gastric tissues (upper panel) from GC patients, which contrasted with the lack of AE2 expression in cancer tissues (bottom panel).
b Statistical analysis of AE2 expression in GC tissues and adjacent normal tissues with n representing the number of specimens. c Expression of AE1
and AE2 in serial GC tissue sections. d AE1 and p16 expression in serial GC tissue sections. e Kaplan-Meier survival curves of overall survival of GC in
terms of AE2, AE1 and p16 protein levels
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Low levels of AE2 and high levels of AE1 and p16
correlated with poor prognosis of GC
To further explore the role of AE2 in inhibition of GC
growth, AE2 expression in samples from 82 gastric can-
cer patients was detected by immunohistochemistry.
AE2 was exclusively expressed in adjacent normal gastric
tissues, but was significantly down-regulated in cancer
tissues (Fig. 5a). Statistical analysis indicated that the ex-
pression frequency of AE2 in GC tissues was 25.6 % (21/
82), which is significantly decreased compared with that
in adjacent normal tissues (82/82) (Fig. 5b). Consistent
with our molecular experiment results (Fig. 2), AE2 ex-
pression was negatively correlated with both AE1 and
p16 expression in GC tissues (Fig. 5c, d). The clinico-
pathological analysis demonstrated that reduced AE2 ex-
pression was associated with poor differentiation of GC
(Table 1). Most importantly, low levels of AE2 and high
levels of AE1 and p16 were correlated with poor survival
of GC patients (Fig. 5e).
Gastrin suppressed the growth of GC cells in vivo and in
vitro through up-regulation of AE2 expression
We previously reported that gastrin inhibited the growth
of AE1- and p16-positive GC cells [25]. To investigate a
potential role for AE2 in mediating gastrin-induced GC
suppression, a SGC7901 xenograft mouse model was
established by subcutaneous injection of 5 × 106 SGC7901
cells. After the initial tumors reached 200 mm3, animals
were randomized into control and experimental groups,
with the control group receiving 0.9 % NaCl, and the ex-
perimental group receiving subcutaneous injections of
gastrin (2 mg/kg, diluted in 0.9 % NaCl) twice daily for
20 days. Tumor suppression was observed after treatment
with gastrin for 17 days (Fig. 6a), and was accompanied by
increased AE2 protein levels in tumor extracts on day 20
(Fig. 6b). To confirm the role of gastrin in AE2 up-
regulation, AE2 expression was detected by western blot
after cells were treated with 10−7 M gastrin for 3 days. The
results showed that gastrin up-regulated AE2 expression,
which was accompanied by down-regulation of cyclin D1




make up the AE family, together with other ion carriers,
are involved in pHi regulation [10, 26, 27]. Under physio-
logical conditions, AE family proteins are generally acti-
vated by intracellular alkalosis. All AE members share three
common structural domains: an N-terminal cytoplasmic
domain, a transmembrane domain and a C-terminal cyto-
plasmic domain, yet their molecular weights differ (AE1:
~95 kDa and AE2: ~170 kDa) [7]. The AE1 gene encodes
full-length erythroid AE1 and a shorter kidney AE1 that in
humans initiates at Met66 [28]. Intracellular trafficking of
AE1 is mediated via interactions with other proteins. For
instance, interplay between AE1 and p16 facilitates AE1
trafficking to the plasma membrane, and also promotes p16
nuclear transport in AE2-positive HEK293T or K562 cells.
Moreover, AE1 expression induces differentiation of the
myelogenous leukemia cell line K562 [19, 24]. These results
suggest that in several cell types, such as renal tubular epi-
thelial cells or hematopoietic cells, AE1 can be transported
to the plasma membrane, and that AE1 and p16 play a
mutually cooperative role in HEK293T and K562 cells.
AE2 and p16 proteins were also normally located at the
plasma membrane and in the nucleus, respectively, in
these cells [17, 24]. On the other hand, AE1, AE2 and
p16 mRNAs could be detected under physiological con-
ditions in gastric epithelial cells. The AE2 mRNA was
translated into proteins, while translation of both AE1
and p16 was normally silenced by several factors, includ-
ing miR-24 and gastrin [24, 25]. In contrast, under patho-
logic conditions such as achlorhydria and H. pylori
infection, AE1 expression is significantly induced and
causes a large accumulation of AE1 in the cytoplasm of
gastric epithelial cells [19, 22]. Such cells lack a route for
AE1 membrane trafficking, leading to sequestration of
AE2 in the cytoplasm that arises in response to
Table 1 Relationship between AE2 expression and
clinicopathological features of gastric cancer
Clinicopathological
features
No.a AE2 expression P value
Negative no. (%) Positive no. (%)
Mean ages (years)
63.6 ± 12.8 174 119 55
Age (years) 0.6247
≤ 65 87 61 (70.11) 26 (29.89)
> 65 87 58 (66.67) 29 (33.33)
Gender 0.4655
Male 107 71 (66.36) 36 (33.64)
Female 67 48 (71.64) 19 (28.36)
Differentiation 0.0005
Well or Moderately 72 39 (54.17) 33 (45.83)
Poorly 101 80 (79.21) 21 (20.79)
Lymph metastasis 0.7668
Negative 39 26 (66.67) 13 (33.33)
Positive 133 92 (69.17) 41 (30.83)
TNM staging 0.0179
I 20 9 (45.00) 11 (55.00)
II–IV 130 93 (71.54) 37 (28.46)
Lauren classification 0.0002
Intestinal type 66 37 (56.06) 29 (43.94)
Diffuse type 82 69 (84.15) 13 (15.85)
Values in parenthesis are percentage
aThe data was partially analyzed due to the unparticular information
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interactions between cytoplasmic AE1 and p16. The cyto-
plasmic AE2 protein may be misfolded and thus more
sensitive to ubiquitin-dependent degradation [29, 30].
These results suggested that AE1 and AE2 do not nor-
mally coexist in the cytoplasm of cells, although AE2 over-
expression can produce protein expression rates that
exceed those of degradation. This undegraded AE2
protein could coexist with AE1 in the cellular cytoplasm.
AE2 is known to be widely expressed in most cell
types, and has a particularly high expression level in gas-
tric parietal cells. Nevertheless, how AE2 protein is re-
moved from cells is unclear. Here we demonstrated that
Fig. 6 Gastrin suppressed GC growth in vivo and in vitro through AE2 up-regulation. a Gastrin induced inhibition of tumor cell proliferation. SGC7901
xenograft-bearing nude mice were treated with 0.9 % NaCl or gastrin. Tumor growth rates were determined by calculating the percentage of change in
tumor volume (T) compared with initial tumor volume (T0). *p< 0.05, compared with control group (n= 10). b Gastrin increased AE2 abundance in tumor
extracts. The ratio of AE2 protein abundance to that of β-actin was normalized to a value of 1.0 for the 0.9 % NaCl group. *p< 0.05, compared with 0.9 %
NaCl group (n= 10). A representative immunoblot is presented below. c Gastrin induced up-regulation of AE2 protein expression and down-regulation of
cyclin D1 protein expression. The ratio of AE2 and cyclin D1 protein abundance to that of β-actin was normalized to a value of 1.0 for the SGC7901 group
(n= 3), *p< 0.05, compared with the SGC7901 group. d Cellular acidification occurred in SGC7901 cells after incubation with 10−7 M gastrin for 24 h. Data
are representative of experiments performed three times in triplicate, *p<0.05, compared with untreated SGC7901 cells. eModel for gastrin-induced inhibition
of GC through up-regulation of AE2 levels, which were decreased by AE1/p16. In GC cells, intracellular retention of AE1 and cytoplasmic sequestration of
p16 lead to increased AE2 ubiquitin-dependent degradation, as well as reduced total and plasmalemmal abundance of AE2. The resulting reduction in
AE2-mediated anion exchange activity may result in cellular alkalinization, leading to increased cyclin D1 expression. Gastrin up-regulates AE2 expression by
blocking formation of the AE1/p16 complex. Enhanced AE2-mediated Cl−/HCO3
− exchange activity acidifies GC cells that in turn retards cell growth
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AE2 is degraded by the ubiquitin proteasome pathway in
GC cells. Aberrant AE2 expression levels could cause
total or partial dysfunction in regulating pHi [7]. Several
studies demonstrated that cytoplasmic pH plays crucial
roles in controlling DNA synthesis, cell growth, prolifer-
ation, differentiation, oncogenesis and malignant trans-
formation [31]. In addition, there is increasing evidence
to support that cancer cells have ‘malignant’ alkaline
pHi, which is consistent with our previous findings [32].
Thus, intracellular alkalinization may be an important
hallmark of GC tumor cells [33, 34]. We speculated that
in GC, impaired AE2 expression in turn elevates the pHi
and reduces acid secretions via interactions with AE1
and p16, which could worsen achlorhydria syndromes
and promote GC progression (Fig. 6e). AE1 was previ-
ously demonstrated to be an unexpected factor that is
responsible for p16 cytoplasmic sequestration and is
associated with both tumor progression and poor prog-
nosis [17, 18]. As such, the nuclear distribution of AE2
requires further investigation.
Conclusions
Here we demonstrated that ectopic expression of AE2
together with AE1 and p16 expression is an important
pathogenic factor in the development of GC, and that
dysfunctional AE2 can be degraded through a ubiquitin-
dependent pathway. Gastrin affects AE2 expression and
thus could be a potential candidate drug for targeting ther-
apy for AE1- and p16-positive GC. Our findings will bring
new perspectives on future clinical treatments for GC.
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